The trade-off of a single-network compounder relationship
VLS Pharmacy and New Drug Loft are a genuine, high-quality 503A compounding network — USP 797/800 sterile facilities, PCCA-certified technicians, LegitScript-certified, and a deep integrative medicine formulary. For a clinic whose entire medication list lives inside the VLS and NDL catalog, the fax-and-EMR submission model works: each Rx goes to the right location and VLS handles the compounding.
The constraint appears when a clinic's formulary spans multiple compounders. A GLP-1 formulation that VLS does not carry, a peptide or BHRT compound that another 503A partner specializes in, or a second-source GLP-1 during high-demand periods all require the clinic to maintain separate accounts, submission flows, and tracking channels for each compounder. Fizy Health is built for exactly that scenario: one cart holds lines for all assigned 503A partners, routing splits automatically after checkout, and per-line tracking keeps everything in one view.